Patient-related benefits for adults with cochlear implantation : a multicultural longitudinal observational study

Lenarz, Thomas ; Muller, Lida ; Czerniejewska-Wolska, Hanna ; Varela, Hector Valles ; Dotu, Cesar Orus ; Durko, Marcin ; Irujo, Alicia Huarte ; Piszczatowski, Bartosz ; Zadrożniak, Marek ; Irwin, Colin ; Graham, Petra L. ; Wyss, Josie (2017-07-19)

CITATION: Lenarz, T., et al. 2017. Patient-related benefits for adults with cochlear implantation : a multicultural longitudinal observational study. Audiology and Neurotology, 22(2):61-73, doi:10.1159/000477533.

The original publication is available at https://www.karger.com

Article

ENGLISH ABSTRACT: To assess subjectively perceived, real-world benefits longitudinally for unilateral cochlear implant (CI) recipients in a multinational population treated routinely. To identify possible predictors of self-reported benefits. Design: This was a prospective, multicenter, repeated-measures study. Self-assessment of performance at preimplantation and postimplantation at 1, 2, and 3 years using standardized, validated, local language versions of the Speech, Spatial, and Qualities of Hearing Scale (SSQ), and the Health Utilities Index Mark 3 (HUI3) was performed. Outcomes were analyzed using a longitudinal mixed-effects model incorporating country effect. Patient demographics were explored for associations with change over time. Subjects: Two hundred ninety-one routinely treated, unilateral CI recipients, aged 13-81 years, from 9 clinics across 4 countries. Results: Highly significant improvements were observed for all outcome measures (p < 0.0001). Postimplantation, mean outcome scores remained stable beyond 1 year, with notable individual variability. A significant association for one or more outcomes with preimplantation contralateral hearing aid use, telephone use, age at implantation, implantation side, preimplantation comorbidities, dizziness, and tinnitus was observed (p < 0.004). Conclusions: Longitudinal benefits of CI treatment can be measured using clinically standardized self-assessment tools to provide a holistic view of patient-related benefits in routine clinical practice for aggregated data from multinational populations. Self-reported outcomes can provide medical-based evidence regarding CI treatment to support decision-making by health service providers.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/105357
This item appears in the following collections: